A bioactive-guided investigation of the hydro-ethanolic extract of aerial parts of Aristeguietia glutinosa Lam. resulted in the isolation of two diterpenoids, (+)-15-hydroxy-labd-7-en-17-al (1) and (+)-13,14,15,16-tetranor-labd-7-en-l7,12-olide (2), as the anti-Trypanosoma cruzi active principles. The structures of 1 and 2 were determined by spectroscopic analysis. The hydro-ethanolic extract showed anti-T. cruzi activity (IC 50 = 19.6 µg/mL) whereas the isolated compounds 1 and 2 were near to seven-and one and a half-fold (IC 50 = 3.0 and 15.6 µg/mL), respectively more active than the original extract. Labdene 1, equipotent as the reference compound (Nifurtimox), displayed low hemolytic activity, low toxicity against murine macrophages, and absence of mutagenicity. These results support the vernacular medicinal use of this plant as an anti-T. cruzi agent.
The genus Aristeguietia (Asteraceae) consists of twenty one species distributed in the Andes from Colombia to south Peru [1, 2] . Plants of this genus have been used in traditional medicine [3, 4] . In Ecuador, nine Andean species have been described, among them A. glutinosa Lam. [1] , traditionally known as Matico, Yerba del soldado, Chuzalongo, Matigo, and Migla, which has been used as an astringent, antirheumatic, antimicrobial, and to treat stomach ulcers, diarrhea, and headaches [5, 6] . Phytochemical and pharmacological studies on A. glutinosa resulted in the identification of compounds with antimicrobial [7, 8] , and antiviral activities [9] . As part of our ongoing pharmacological studies of Andean-Ecuadorian plants, we analyzed the hydro-ethanolic extract of A. glutinosa against bacteria (B. subtilis, S. epidermidis, S. aureus, E. coli, P. aeruginosa, K. pneumoniae, and S. typhi) and fungi (T. rubrum, and M. canis) and observed excellent antifungal activity in the same order as that of the control (griseofulvin) [10] .
American trypanosomiasis or Chagas disease, one of the most prevalent parasitic diseases, is caused by the protozoan Trypanosoma cruzi [11] . Research during the last two decades has consistently demonstrated that T. cruzi, like most fungi and yeasts, requires specific sterols for cell viability and proliferation in all stages of its life cycle. In particular, the ergosterol biosynthesis pathway has been chemically validated in vitro as a target for the development of new therapeutic, anti-T. cruzi agents [12] . Bioassay-guided fractionation [14] was undertaken of a hydroethanolic extract of the flowering aerial parts of A. glutinosa ( Figure  1 , Table 1 ), resulting in the isolation of the labdene diterpenoid aldehyde 1 and the labdene lactone 2.
From spectroscopic and mass spectrometric data, compound 1 was shown to be 15-hydroxy-7-labden-17-al, and compound 2, 13,14,15,16-tetranor-labd-7-en-l7,12-olide. Both compounds were dextrorotatory, confirming the labdane nucleus [15] . Diterpenoid 1 was previously reported from Baccharis pedunculata [16] , but only 1 H NMR data were used to characterize it. For lactone 2, there is only one report dealing with its isolation from a natural source, but this describes the enantiomer ([α] D = -17.0) [13] . The fraction F3 was composed by a mixture of compounds and attempts to purify each one were unsuccessful. However, according to the spectroscopic data and some assayed reaction the main product also corresponded to a labdene-derivative with three alcohol moieties probably a miogatrial-like metabolite [17, 18] .
Compound 1 displayed a similar IC 50 value to the reference drug, Nifurtimox, 9.8 and 7.7 M, respectively ( To explore the potential of the extract, sub-extracts or isolated compounds as drugs, we performed three different studies. First, we evaluated the in vitro capability for red blood cells lysis; secondly, unspecific mammal cytotoxicity, using J-774 mouse macrophages; and thirdly, the mutagenicity capacity using the Salmonella typhimurium mutagenicity-assay (Ames test). Because some labdanes have been described as hemolytic agents or erythrocyte membrane-modifiers [19] [20] [21] , we used the hemolytic ability of fractions and isolated compounds as a selectivity indicator. In this sense, the hydro-ethanolic extract of A. glutinosa displayed significant hemolytic activity (Table 2) , with a selectivity index lower than 0.6. However, the toxic effects of the isolated compounds were greatly diminished with aldehyde 1 17.3-fold-and lactone 2 32.7-fold less hemolytic than the reference compound (amphotericin B), and reaching a value for the parasite-selectivity index of 2.2, in the case of labdene 1. Additionally, 1 and 2 did not display significant cytotoxicities against murine macrophages J774 at doses at least two-fold higher than the corresponding T. cruzi-IC 50 s {aldehyde 1 a SI (IC 50, J774 / IC 50, T. cruzi ) of 3.3}.
In these assays, Nifurtimox, the anti-T. cruzi reference drug, displayed lower cytotoxicities against mammalian cells than labdenes 1 and 2 (Table 2 ) [22, 23] , but possesses mutagenic effects (Table 2 ) [24] . We studied the mutagenic potential of the different fractions and compounds 1 and 2 using the Ames test (Table S1 , Supplementary data). The original hydro-ethanolic extract, the nhexane fraction and the isolated compounds from the methanolic fraction, 1 and 2, were non-mutagenic (Table 2 ) in either the absence or presence of the S9 fraction to simulate in vivo metabolism.
Current treatment of Chagas disease is limited to only two drugs, Nifurtimox and Benznidazole, but they have mutagenic effects [24] . In this study we have shown that A. glutinosa possessed in vitro active components against T. cruzi and without mutagenic effects. This could at least support the vernacular medicinal use of A. glutinosa as an anti-Chagas agent. Studies to investigate the in vivo activity of the hydro-ethanolic extract and each isolated compound are currently underway.
Experimental
General: UV, ACTGene-Nanodro; IR, Shimadzu IRPRESTIGE-21; NMR, Bruker AVANCE DPX-400 spectrometer; Optical rotations, P8000 A Kruss Optronic digital polarimeter; LC-MS, Agilent microTOF-Q; Samples were analyzed using a reversed-phase C18 analytical column with 150 mm length, 4.6 mm diameter and 5 mm particle size, maintained at 40°C. The injection volume was 5 µL. The mobile phase consisted of 10 mM ammonium acetate in ultra pure water (A) and acetonitrile (B) (JT Baker). Flow rate was 0.8 mL/min split in a 1:1 ratio before introduction to the mass spectrometer. The chromatographic method consisted of a linear gradient from 5 to 100% B in 60 min and a isocratic step of 100% B for 2 min, followed by re-equilibration at 5% B, with a total run time of 70 min. The wavelength of the DAD was set at 274 nm, 220 nm, 520 nm and 650 nm, and the on-line UV-Vis spectra were recorded in the range 190-800 nm.
Plant materials: Aristeguietia glutinosa Lam. plants were collected in 2007 from the "Pangor" plateau, Quito, Ecuador, a region without insecticide treatments. An identified voucher sample has been deposited in the herbarium of the Escuela de Bioquímica y Farmacia, Facultad de Ciencias Químicas, Universidad Central, Ecuador.
Hydro-ethanolic extract:
The plant material (leaves, inflorescences, and twigs), dried and ground, was extracted 3 times with aqueous ethanol (72%) at room temperature, each for 2 days, with occasional stirring. After filtration, the extracts were combined and evaporated in vacuo to give oily material. 
Anti-T. cruzi activity:
Trypanosoma cruzi epimastigotes (Tulahuen 2 strain) were grown at 28ºC in an axenic medium (BHI-Tryptose), as previously described [13, 22] , supplemented with 5% fetal bovine serum (FBS). Cells from a 10-day-old culture (stationary phase) were inoculated into 50 mL of fresh culture medium to give an initial concentration of 1  10 6 cells/mL. Cell growth was followed by measuring the absorbance of the culture at 600 nm every day. Before inoculation, the media was supplemented with the indicated quantity of the extracts or isolated compounds from a stock solution in DMSO. The final concentration of DMSO in the culture media never exceeded 0.4%, and the control was run in the presence of 0.4% DMSO and in the absence of studied extracts or compounds. No effect on epimastigote growth was observed due to the presence of up to 1% DMSO in the culture media. The percentage of inhibition (PGI) was calculated as follows: PGI (%) = {1 -[(ApA0p)/(Ac -A0c)]}  100, where Ap = A 600 of the culture containing the drug at day 5; A0p = A 600 of the culture containing the drug just after addition of the inocula (day 0); Ac = A 600 of the culture in the absence of drugs (control) at day 5; A0c = A 600 in the absence of the drug at day 0. In order to determine IC 50 values, 50% inhibitory concentrations, parasite growth was followed in the absence (control) and presence of increasing concentrations of the corresponding extract or compound. At day 5, the absorbance of the culture was measured and related to the control. The IC 50 value was taken as the concentration of extract or compound needed to reduce the absorbance ratio to 50%.
Red blood cell lysis assay [26, 27] : Human blood collected in sodium citrate solution (3.8%) was centrifuged at 200 g for 10 min at 4 o C. The plasma supernatant was removed and erythrocytes were suspended in ice cold PBS. The cells were again centrifuged at 200 g for 10 min at 4°C. This procedure was repeated 2 more times to ensure the removal of any released hemoglobin. Once the supernatant was removed after the last wash, the cells were suspended in PBS to 2% w/v red blood cell solution. A volume of 400 μL of extract or compound to be analyzed, in PBS, negative control (solution of PBS), or Amphotericin B (final dose 1.5 µM) were added to the 2% w/v red blood cell solution. Five replicates for each concentration were prepared, and were incubated for 24 h at 37°C prior to analysis. Complete hemolysis was attained using neat water yielding the 100% control value (positive control). After incubation, the tubes were centrifuged and the supernatants were transferred to new tubes. The release of hemoglobin into the supernatant was determined spectrophotometrically at 405 nm using an EL 301 MICROWELL STRIP READER. Results are expressed as percentage of total hemoglobin released in the presence of the compounds. This percentage was calculated using the equation percentage hemolysis (%) = [(A1 -A0)/ A1 water] × 100, where A1 is the absorbance at 405 nm of the test sample at t= 24 h, A0 is the absorbance at 405 nm of the test sample at t= 0 h, and A1 water is the absorbance at 405 nm of the positive control (water) at t= 24 h. The experiments were replicated in quintuplicate.
Unspecific mammalian cytotoxicity [22] : J-774 murine macrophage-like cells (ATCC, USA) were maintained by passage in Dulbecco's modified Eagle's medium (DMEM) containing 4 mM L-glutamine, and supplemented with 10% heat-inactivated fetal calf serum. J-774 cells were seeded (1  10 5 cells/well) in 96 well microplates with 200 L of RPMI 1640 medium supplemented with 20% heat inactivated fetal calf serum. Cells were allowed to attach for 48 h in a humidified 5% CO 2 /95% air atmosphere at 37ºC and, then, exposed to extracts or compounds for 48 h. Afterwards, cell viability was assessed by measuring the mitochondrial-dependent reduction of MTT (Sigma) to formazan. For that purpose, MTT was added to cells to a final concentration 0.4 mg/mL and cells were incubated at 37°C for 3 h. After removing the media, formazan crystals were dissolved in DMSO (180 L), and the absorbance at 595 nm was read using a microplate spectrophotometer. Results are expressed as IC 50 (extract or compound concentration that reduce 50 % control absorbance at 595 nm). Every IC 50 is the average of five different experiments.
Mutagenicity assay [28]:
The method of direct incubation in the plate was performed. A culture of Salmonella typhimurium TA98 strain in agar minimum glucose medium (AMG)-agar solution, Vogel Bonner E(VB) 50, and 40% glucose solution-was used. First, the direct toxicity of the compounds under study against S. typhimurium TA98 strain was assayed. DMSO solutions of extract or compounds at different doses (starting at the highest doses without toxic effects) were assayed in duplicate. Positive controls of 4-nitro-o-phenylendiamine (20.0 g/plate, in the run without S9 activation) and 2-aminofluorene (10.0 g/plate, in the cases of S9 activation) and negative control of DMSO were run in parallel. The influence of metabolic activation was tested by adding 500 L of S9 fraction of mouse liver treated with Aroclor, obtained from Moltox, Inc. (Annapolis, MD, USA). The revertant number was counted manually. The sample was considered mutagenic when the number of revertant colonies was at least double that of the negative control for at least 2 consecutive dose levels [29] .
